Zepp Health (FRA:ST0) Other Current Receivables: €5.3 Mil (As of Mar. 2026)


FRA:ST0 Zepp Health Corp FRA:ST0
39 GF Score
Price €4.50
GF Value €3.27
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Zepp Health Other Current Receivables?

Zepp Health FRA:ST0 +5.14% 39 Other Current Receivables is €5.3 Mil as of Mar. 2026. GuruFocus rates FRA:ST0 with a GF Score™ of 39/100 and a GF Value™ of €3.27 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Zepp Health's Other Current Receivables for the quarter that ended in Mar. 2026 was €5.3 Mil.

Zepp Health's quarterly Other Current Receivables increased from Sep. 2025 (€3.77 Mil) to Dec. 2025 (€26.21 Mil) but then stayed the same from Dec. 2025 (€26.21 Mil) to Mar. 2026 (€5.33 Mil).

Zepp Health's annual Other Current Receivables declined from Dec. 2023 (€19.47 Mil) to Dec. 2024 (€15.45 Mil) but then increased from Dec. 2024 (€15.45 Mil) to Dec. 2025 (€26.21 Mil).

Zepp Health Other Current Receivables Related Terms

Zepp Health Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Zepp Health's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zepp Health Other Current Receivables Chart

Zepp Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.48 25.75 19.47 15.45 26.21

Zepp Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.39 3.17 3.77 26.21 5.33
FRA:ST0
39GF Score
Zepp Health Corp FRA:ST0
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zepp Health Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €5.3 Mil mean?
Zepp Health (FRA:ST0) has a Other Current Receivables of €5.3 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Zepp Health and its competitors.
Is Zepp Health's Other Current Receivables too high?
Zepp Health's current Other Current Receivables is €5.3 Mil. Overall, Zepp Health has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zepp Health's Other Current Receivables compare to UEIC and AXIL?
Zepp Health's Other Current Receivables of €5.3 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Hardware company?
A good Other Current Receivables depends on the Hardware industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Zepp Health and its competitors. Zepp Health's current Other Current Receivables is €5.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zepp Health stock overvalued right now?
Based on GuruFocus' analysis, Zepp Health (FRA:ST0) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.27, compared to a current price of €4.50 — trading 37.6% above its estimated fair value. The current Other Current Receivables is €5.3 Mil. Zepp Health's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Zepp Health (FRA:ST0), the current Other Current Receivables is €5.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zepp Health (FRA:ST0) Overvalued in 2026?

Based on GuruFocus' analysis, Zepp Health stock appears to be overvalued. The current stock price of €4.50 is trading 37.6% above its estimated GF Value™ of €3.27. GuruFocus considers Zepp Health to be Significantly Overvalued.

Key valuation signals for FRA:ST0:

  • Other Current Receivables: €5.3 Mil
  • GF Value™: €3.27 vs. price of €4.50 (37.6% above fair value)
  • GF Score™: 39/100 with 3 warning signs

No single metric tells the full story. See the FRA:ST0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zepp Health Business Description

Other Exchanges ZEPP:USA
Address Edisonweg 44 - B08, Gorinchem, ZH, NLD, 4207 HG
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
39GF Score

Get the complete analysis for FRA:ST0

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.50
Price
€3.27
GF Value